The most researched repair peptide and how it accelerates healing.
BPC-157 stands for Body Protection Compound-157. It is a synthetic 15-amino-acid peptide whose sequence is derived from a region of Body Protection Compound (BPC), a protein naturally present in human gastric juice. The parent protein is much larger — BPC-157 is a specific fragment selected for its remarkable ability to protect and repair tissues throughout the body, not just the stomach where the parent compound was identified. While your body produces the larger BPC protein naturally, BPC-157 itself is a laboratory-synthesized fragment optimized for therapeutic research.
BPC-157 is a synthetic peptide fragment derived from a naturally occurring gastric protein — it leverages your body's own repair signaling but is itself a laboratory-created compound.
BPC-157 works through multiple pathways simultaneously. It upregulates growth factor receptors (VEGF, FGF), promoting new blood vessel formation. It modulates nitric oxide pathways, reducing inflammation while increasing blood flow to damaged tissues. It interacts with the dopaminergic system, which is why it shows neuroprotective properties. And it directly stimulates tendon fibroblasts, accelerating the production of new connective tissue.
BPC-157 is uniquely multi-targeted — it promotes blood vessel growth, reduces inflammation, protects neurons, and directly stimulates tissue repair cells.
BPC-157 has been studied in over 100 peer-reviewed studies. Research has demonstrated efficacy in tendon and ligament repair, gut healing (IBD, leaky gut), muscle tears, bone fractures, nerve damage, and even organ protection. Most studies are preclinical (animal models), but the consistency across different tissue types and injury models is remarkable. Human clinical trials are underway for several indications. **Research Status**: Moderate preclinical evidence with limited human data. Over 100 animal studies showing consistent healing effects across multiple tissue types, but large-scale human randomized controlled trials are still lacking. No FDA approval.
100+ preclinical studies across multiple tissue types show consistent healing effects — BPC-157 is one of the most validated repair peptides in preclinical research, though human clinical trial data remains limited.